JP2011525506A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525506A5
JP2011525506A5 JP2011515168A JP2011515168A JP2011525506A5 JP 2011525506 A5 JP2011525506 A5 JP 2011525506A5 JP 2011515168 A JP2011515168 A JP 2011515168A JP 2011515168 A JP2011515168 A JP 2011515168A JP 2011525506 A5 JP2011525506 A5 JP 2011525506A5
Authority
JP
Japan
Prior art keywords
formula
heart failure
disease
alkyl
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011515168A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/004390 external-priority patent/WO2009156089A1/en
Publication of JP2011525506A publication Critical patent/JP2011525506A/ja
Publication of JP2011525506A5 publication Critical patent/JP2011525506A5/ja
Withdrawn legal-status Critical Current

Links

JP2011515168A 2008-06-25 2009-06-18 心不全を処置するためのジアリールウレア類 Withdrawn JP2011525506A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08011471.3 2008-06-25
EP08011471 2008-06-25
PCT/EP2009/004390 WO2009156089A1 (en) 2008-06-25 2009-06-18 Diaryl ureas for treating heart failure

Publications (2)

Publication Number Publication Date
JP2011525506A JP2011525506A (ja) 2011-09-22
JP2011525506A5 true JP2011525506A5 (enExample) 2012-11-08

Family

ID=41136709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011515168A Withdrawn JP2011525506A (ja) 2008-06-25 2009-06-18 心不全を処置するためのジアリールウレア類

Country Status (13)

Country Link
US (1) US20110263657A1 (enExample)
EP (1) EP2293792A1 (enExample)
JP (1) JP2011525506A (enExample)
KR (1) KR20110031294A (enExample)
CN (1) CN102076338A (enExample)
AU (1) AU2009262599A1 (enExample)
BR (1) BRPI0914636A2 (enExample)
CA (1) CA2729050A1 (enExample)
IL (1) IL209647A0 (enExample)
MX (1) MX2010014441A (enExample)
RU (1) RU2011102471A (enExample)
WO (1) WO2009156089A1 (enExample)
ZA (1) ZA201009063B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718703B (zh) * 2011-03-31 2016-09-14 中国医学科学院药物研究所 Gk和ppar双重激动活性的含有二甲基的芳基脲类衍生物
JP2014527511A (ja) 2011-06-24 2014-10-16 アムジエン・インコーポレーテツド Ｔｒｐｍ８拮抗剤及び治療におけるそれらの使用
EP2723718A1 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
RU2646454C2 (ru) * 2013-11-12 2018-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Способ моделирования алкогольной кардиомиопатии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004011340T2 (de) * 2003-05-20 2008-11-06 Bayer Healthcare Llc Diaryl-harnstoffe mit kinasehemmender wirkung
NZ544920A (en) * 2003-07-23 2009-11-27 Bayer Healthcare Llc 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
US20090197922A1 (en) * 2006-01-24 2009-08-06 The University Of Chicago Compositions and methods for treating pulmonary hypertension
WO2009092442A1 (en) * 2008-01-23 2009-07-30 Universidad De Barcelona Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways

Similar Documents

Publication Publication Date Title
KR100204433B1 (ko) 4-아미노피리미딘 유도체
JP2007507551A5 (enExample)
JP2011525506A5 (enExample)
JPWO2003064410A1 (ja) 新規１，２，４−トリアゾール系化合物
WO2014003153A1 (ja) 置換アミド化合物
JP2006143737A5 (enExample)
JP2000273089A (ja) 含窒素複素環化合物
JP2011507868A5 (enExample)
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
CA2623294C (en) 2-aminoethoxyacetic acid derivatives and their use
JP2015164972A5 (enExample)
KR102623474B1 (ko) 5-리폭시게나제 활성화 단백질(flap) 억제제로서 유용한 피라졸 유도체
US9745282B2 (en) Indoline compounds as aldosterone synthase inhibitors
RU2011102471A (ru) Диарилмочевины для лечения сердечной недостаточности
WO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
US20220112217A1 (en) Pyrazolopyrimidine derivative and use thereof as pi3k inhibitor
JP2011500619A (ja) 新規なｎｏ−供与アスピリン誘導体
JP2008521844A (ja) 環状イミノカルバメート類およびそれらの使用
RU2008149917A (ru) Производные фенилпентадиеноила и их применение в качестве антагонистов par 1
Wang et al. Design and development of novel pyrazole-thiadiazole derivatives as NF-ĸB Inhibitor and cardioprotective effect against isoproterenol induced myocardial infarction in Sprague-Dawley rats
JP2002255813A (ja) 蛋白修飾物生成抑制剤および方法
Zhang et al. Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors.
US9199947B2 (en) Biaryl-propionic acid derivatives and their use as pharmaceuticals
TW200529840A (en) New pyridin-2-one compounds useful as inhibitors of thrombin
JP2010180183A (ja) 新規なピリミジン−４（３ｈ）−オン構造を有する化合物及びこれを含有する医薬